MI
INBX icon

MMCAP International’s Inhibrx INBX Stock Holding History

MMCAP International’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-112,858
Closed -$1.6M – 172
2024
Q2 		$1.6M Buy
+112,858
New +$1.76M 0.22% 39

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MMCAP International's INBX Position: Q3 2024 in Review

MMCAP International sold out of Inhibrx (INBX) in Q3 2024, closing a stake of 112,858 shares — an estimated $1.6M sold.

MMCAP International first reported a position in INBX in Q2 2024 and held it in 1 quarter. The position peaked at $1.6M in Q2 2024. 96 funds tracked by Wall St. Rank hold INBX as of Q3 2024.

  • MMCAP International reported no remaining Inhibrx position as of Q3 2024 after selling out during the quarter.
  • MMCAP International sold 112,858 Inhibrx shares in Q3 2024, an estimated $1.6M.
  • MMCAP International first reported a position in Inhibrx in Q2 2024 and held it in 1 quarter.
  • MMCAP International's Inhibrx position peaked at $1.6M in Q2 2024.
  • 96 funds tracked by Wall St. Rank held Inhibrx as of Q3 2024.

Based on MMCAP International's 13F filing for Q3 2024, filed 12 Nov 2024.